The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure.
about
Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).Epoprostenol (Veletri®, Caripul®): a review of its use in patients with pulmonary arterial hypertension.
P2860
The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
The effects of epoprostenol on ...... with congestive heart failure.
@en
The effects of epoprostenol on ...... with congestive heart failure.
@nl
type
label
The effects of epoprostenol on ...... with congestive heart failure.
@en
The effects of epoprostenol on ...... with congestive heart failure.
@nl
prefLabel
The effects of epoprostenol on ...... with congestive heart failure.
@en
The effects of epoprostenol on ...... with congestive heart failure.
@nl
P2093
P2860
P1476
The effects of epoprostenol on ...... with congestive heart failure.
@en
P2093
Carlton LD
Mattson CN
Patterson JH
Schmith VD
P2860
P304
P356
10.1002/J.1552-4604.1996.TB04196.X
P577
1996-03-01T00:00:00Z